About Inquis Medical
Inquis Medical is a company based in Redwood City (United States) founded in 2019.. Inquis Medical has raised $115 million across 2 funding rounds from investors including Marshall Wace, ShangBay Capital and Yu Galaxy. Inquis Medical offers products and services including AVENTUS Thrombectomy System and AVENTUS Clot Management System. Inquis Medical operates in a competitive market with competitors including Orchestra BioMed, Biotronik, Spectrumedics, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115 M (USD)
in 2 rounds
-
Latest Funding Round
$75 M (USD), Series C
Jan 12, 2026
-
Investors
Marshall Wace
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inquis Medical
Inquis Medical offers a comprehensive portfolio of products and services, including AVENTUS Thrombectomy System and AVENTUS Clot Management System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for non-surgical removal of blood clots in vasculature.
System for autologous blood transfusion during procedures.
Funding Insights of Inquis Medical
Inquis Medical has successfully raised a total of $115M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $75.0M
-
First Round
First Round
(04 Nov 2024)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series C - Inquis Medical | Valuation |
investors |
|
| Nov, 2024 | Amount | Series B - Inquis Medical | Valuation | Marshall Wace |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inquis Medical
Inquis Medical has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Marshall Wace, ShangBay Capital and Yu Galaxy. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-short equity strategies are managed through specialized hedge funds.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in innovative founders by Yu Galaxy.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inquis Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inquis Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inquis Medical Comparisons
Competitors of Inquis Medical
Inquis Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchestra BioMed, Biotronik, Spectrumedics, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for hypertension and atherosclerosis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cardiovascular products and equipment are developed, manufactured, and distributed.
|
|
| domain | founded_year | HQ Location |
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Extracorporeal circulation products including ECMO are developed for medical support.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inquis Medical
Frequently Asked Questions about Inquis Medical
When was Inquis Medical founded?
Inquis Medical was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Where is Inquis Medical located?
Inquis Medical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Inquis Medical?
Vahid Saadat is the current CEO of Inquis Medical.
Is Inquis Medical a funded company?
Inquis Medical is a funded company, having raised a total of $115M across 2 funding rounds to date. The company's 1st funding round was a Series B of $40M, raised on Nov 04, 2024.
What does Inquis Medical do?
Inquis Medical was founded in 2019 and is headquartered in Redwood City, United States. Focus is placed on the development of medical devices targeted at peripheral thrombectomy procedures within the healthcare sector. Operations involve engineering solutions for vascular interventions, with emphasis on device efficacy for clot removal. The company is led by CEO Vahid Saadat, and activities are conducted primarily in the United States medical device industry.
Who are the top competitors of Inquis Medical?
Inquis Medical's top competitors include Orchestra BioMed, Biotronik and Spectrumedics.
What products or services does Inquis Medical offer?
Inquis Medical offers AVENTUS Thrombectomy System and AVENTUS Clot Management System.
Who are Inquis Medical's investors?
Inquis Medical has 5 investors. Key investors include Marshall Wace, ShangBay Capital, Yu Galaxy, Pierre Lamond, and EnPointe Ventures.